Related Experiment Video
Updated: Aug 14, 2025

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Coronary Revascularization in Patients With Diabetes: A Meta-Analysis of Randomized Controlled Trials and
Adham Ahmed1, Kathryn S Varghese1, Peter J Fusco1
1City University of New York School of Medicine, New York, NY, USA.
Insights
Coronary artery bypass grafting (CABG) shows better long-term outcomes than percutaneous coronary intervention (PCI) for patients with diabetes and coronary artery disease (CAD). CABG reduces mortality, myocardial infarction, and repeat revascularization compared to PCI.
Area of Science:
- Cardiology
- Interventional Cardiology
- Diabetology
Background:
- Patients with diabetes mellitus often experience poorer outcomes with coronary artery disease (CAD).
- Revascularization strategies for diabetic patients with CAD require careful consideration due to unique clinical challenges.
Approach:
- A pairwise meta-analysis was conducted on randomized controlled trials (RCTs) and propensity-matched observational studies (PMS).
- The analysis compared coronary artery bypass grafting (CABG) against percutaneous coronary intervention (PCI) in diabetic patients with concurrent CAD.
- Primary outcomes included mortality, myocardial infarction (MI), major adverse cardiac and cerebrovascular events (MACCE), and repeat revascularization.
Key Points:
- PCI was associated with significantly higher long-term all-cause mortality, cardiac mortality, MI, MACCE, and repeat revascularization compared to CABG.
- No significant difference in long-term stroke rates was observed between PCI and CABG.
- Meta-regression indicated that a higher proportion of female patients in studies correlated with reduced CABG benefit for mortality but increased benefit for MI and repeat revascularization.
Conclusions:
- Coronary artery bypass grafting (CABG) demonstrates superior long-term clinical outcomes, including reduced mortality and repeat revascularization, for diabetic patients with CAD compared to percutaneous coronary intervention (PCI).
- Further research is warranted to investigate the influence of gender on revascularization outcomes in this patient population.
Objective:
Patients with diabetes have poorer outcomes with coronary artery disease (CAD) and pose a unique clinical population for revascularization. We performed a pairwise meta-analysis of randomized trials (RCTs) and propensity-matched observational studies (PMS) to compare the clinical outcomes of coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) in patients with diabetes.
Methods:
A comprehensive literature search was performed to identify RCT and PMS studies comparing CABG with PCI in patients with diabetes with concurrent CAD. Studies were pooled using the random-effects model to perform a pairwise meta-analysis. Primary outcomes included long-term all-cause mortality, cardiac mortality, myocardial infarction (MI), major adverse cardiac and cerebrovascular events (MACCE), and repeat revascularization. Meta-regression was used to explore the effects of baseline risk factors on primary outcomes with moderate to high heterogeneity.
Results:
A total of 18 RCTs and 9 PMS with 28,846 patients were included. PCI was associated with increased long-term all-cause mortality (risk ratio [RR] = 1.34, P < 0.001), cardiac mortality (RR = 1.52, P < 0.001), MI (RR = 1.51, P = 0.009), MACCE (RR = 1.65, P < 0.001), and repeat revascularization (RR = 2.48, P < 0.001) compared with CABG. There was no difference in long-term stroke between the 2 groups (RR = 0.95, P = 0.82). At meta-regression, a greater proportion of female patients in studies was associated with a decreased protective benefit for CABG for long-term all-cause mortality but an increased protective benefit for long-term MI and repeat revascularization.
Conclusions:
Revascularization of patients with diabetes using CABG is associated with significantly reduced long-term mortality, MI, MACCE, and repeat revascularizations. Future studies exploring the influence of gender on revascularization outcomes are necessary to elucidate the ideal treatment modality in patients with diabetes.
More Related Videos
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Coronary Artery Disease II: Pathophysiology

